Agilent Technologies, Inc.

A Healthcare Diagnostics & Research

Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

172.96 2.59 −1.48%
Market cap
$49.5B
P/E
34.0×
Fwd P/E
26.3×
Dividend yield
0.59%
F-score
5/9
Altman Z
5.46
Beneish M
−2.46
Dividend safety
86/100
Oct '25 Oct '24 Oct '23 Oct '22 Oct '21 Oct '20 Oct '19 Oct '18 Oct '17 Oct '16
P/E ratio
31.96 29.35 24.50 32.94 39.46 45.17 22.35 64.79 31.94 30.90
Piotroski F-Score
5 5 6 7 7 5 5 7 8 8
P/S ratio
5.98 5.80 4.45 6.04 7.56 6.09 4.61 4.23 4.90 3.38
Altman Z-Score
5.46 5.07 5.15 6.17 6.69 5.08 4.05 4.39 4.90 4.71
Altman Z″-Score (non-manufacturers)
3.48 3.23 3.90 3.39 3.30 3.02 2.49 3.85 4.27 6.60
P/FCF ratio
36.02 27.58 20.66 40.64 36.87 40.50 27.47 22.83 30.72 21.72
Beneish M-Score
(2.46) (2.64) (2.72) (2.34) (2.49) (2.48) (2.24) (2.79) (2.47) (2.64)
P/Operating CF
76.27 78.57 58.90 92.34 108.27 86.26 75.75 55.91 76.06 60.70
Dividend Safety Score
86 — — — — — — — — —
P/B ratio
6.17 6.41 5.20 7.80 8.86 6.67 5.01 4.55 4.53 3.35
Price to Tangible BV
22.80 43.24 21.55 77.76 110.27 73.91 495.53 18.79 11.73 10.82
EV/Sales
6.16 6.11 4.62 6.29 7.74 6.25 4.69 4.14 4.70 3.29
EV/EBITDA
24.24 22.81 19.45 22.25 29.32 28.91 20.52 18.27 20.64 16.05
EV/Operating CF
27.47 22.73 17.80 32.81 32.93 36.22 23.70 18.72 23.65 17.43
EV/FCF
37.11 29.06 21.44 42.29 37.76 41.55 27.94 22.34 29.49 21.13
Quick Ratio
1.40 1.40 1.80 1.32 1.61 1.69 1.11 2.58 2.69 3.09
Current Ratio
1.96 2.09 2.61 2.03 2.22 2.33 1.53 3.29 3.30 3.85
Net Debt/EBITDA
0.71 1.16 0.71 0.87 0.69 0.73 0.35 (0.40) (0.86) (0.45)
Debt/Assets
23.96% 28.24% 25.41% 25.95% 25.49% 23.72% 18.95% 21.06% 21.37% 24.43%
Debt/Equity
0.45 0.57 0.47 0.52 0.51 0.47 0.38 0.39 0.37 0.45
Asset Turnover
0.57 0.58 0.64 0.64 0.62 0.56 0.57 0.58 0.55 0.55
Operating CF/Net income
1.20 1.36 1.43 1.05 1.23 1.28 0.95 3.44 1.30 1.72
Capex/Depreciation
(1.41) (1.47) (1.10) (0.92) (0.59) (0.38) (0.66) (0.84) (0.83) (0.56)
Interest Coverage
13.21 15.50 14.21 19.26 16.63 10.85 12.72 12.05 10.22 8.54
ROE
20.62% 21.95% 22.24% 23.45% 23.58% 14.95% 22.99% 6.72% 15.06% 10.98%
ROA
10.61% 11.40% 11.65% 11.81% 11.90% 7.54% 11.90% 3.72% 8.43% 6.05%
ROIC
11.55% 11.75% 12.07% 14.48% 12.87% 9.25% 11.40% 13.70% 12.74% 9.96%
Return on Tangible Assets
30.52% 33.55% 32.18% 41.56% 39.86% 25.74% 54.67% 9.03% 18.67% 13.88%
Average Days of Receivables
78.12 74.23 68.96 74.89 67.70 70.96 65.75 57.64 59.09 54.81
Research and Development Expense of Revenue
6.55% 7.36% 7.04% 6.82% 6.98% 9.27% 7.82% 7.88% 7.63% 7.83%
Selling, General and Administrative Expense of Revenue
24.60% 24.09% 23.91% 23.90% 25.62% 28.02% 28.28% 28.27% 27.97% 29.82%
Intangible Assets out of Total Assets
0.39 0.42 0.41 0.45 0.46 0.46 0.50 0.41 0.35 0.38
Share Based Compensation of Revenue
1.84% 1.98% 1.62% 1.83% 1.74% 1.55% 1.39% 1.42% 1.34% 1.38%
Graham Net Nets
(0.03) (0.05) (0.02) (0.03) (0.03) (0.04) (0.06) (0.01) 0.03 0.01
Graham Number
49.46 45.08 43.45 40.95 39.84 28.75 33.96 17.90 26.83 20.33
Earnings Yield
3.13% 3.41% 4.08% 3.04% 2.53% 2.21% 4.48% 1.54% 3.13% 3.24%
Free Cash Flow Yield
2.78% 3.63% 4.84% 2.46% 2.71% 2.47% 3.64% 4.38% 3.25% 4.60%
Revenue per Share
24.46 22.45 23.24 22.90 20.79 17.28 16.44 15.31 13.89 12.89
Operating CF per Share
5.49 6.04 6.03 4.39 4.88 2.98 3.25 3.39 2.76 2.43
Capex per Share
(1.43) (1.30) (1.01) (0.97) (0.62) (0.38) (0.50) (0.55) (0.55) (0.43)
Free Cash Flow per Share
4.06 4.73 5.01 3.41 4.27 2.60 2.75 2.84 2.21 2.01
Cash per Share
6.30 4.58 5.41 3.52 5.18 4.66 4.40 7.00 8.32 7.02
Shareholders Equity per Share
23.74 20.34 19.88 17.74 17.73 15.77 15.12 14.24 15.02 13.02
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
23.74 20.34 19.88 17.74 17.73 15.77 15.12 14.24 15.02 13.02
Free Cash Flow
1,152.00 1,373.00 1,474.00 1,021.00 1,297.00 803.00 865.00 911.00 713.00 654.00
Working Capital
2,247.00 2,064.00 2,583.00 1,917.00 2,091.00 1,948.00 1,109.00 2,677.00 2,906.00 2,690.00
Capital Expenditures
(407.00) (378.00) (298.00) (291.00) (188.00) (118.00) (156.00) (176.00) (176.00) (139.00)
Net Current Asset Value
(1,392.00) (1,989.00) (732.00) (1,449.00) (1,517.00) (1,339.00) (1,515.00) (122.00) 578.00 87.00
EV/EBIT
28.96 26.75 23.36 26.60 36.30 39.44 25.71 22.51 26.06 22.47
Capex to Sales
0.06 0.06 0.04 0.04 0.03 0.02 0.03 0.04 0.04 0.03
Price to Operating Income
28.10 25.40 22.51 25.57 35.45 38.44 25.28 23.01 27.14 23.10
Other line items
Depreciation/Fixed assets
0.14 0.14 0.21 0.29 0.34 0.36 0.28 0.26 0.28 0.39
Cash ROIC
9.95% 12.99% 14.49% 11.23% 13.38% 9.34% 10.92% 10.57% 7.66% 7.75%
Accounts Receivable Turnover
4.94 4.98 5.07 5.31 5.72 5.43 6.05 6.55 6.60 6.79
Accounts Payable Turnover
5.96 6.21 6.75 6.09 7.28 7.07 6.80 6.93 7.38 7.48
Inventory Turnover
3.31 2.97 3.26 3.35 3.76 3.58 3.58 3.68 3.74 3.73
Average Days of Payables
62.95 66.25 45.30 67.72 55.90 51.64 54.80 55.55 53.70 46.79
Days of Inventory on Hand
113.20 119.25 111.73 121.20 104.04 105.04 105.10 104.24 101.24 97.03
Average Receivables
1,405.50 1,307.50 1,348.00 1,288.50 1,105.00 984.00 853.00 750.00 677.50 618.50
Average Payables
555.00 479.00 499.00 513.00 400.00 354.00 347.00 322.50 281.00 268.00
Average Inventory
998.50 1,001.50 1,034.50 934.00 775.00 699.50 658.50 606.50 554.00 537.00
Average Assets
12,286.50 11,304.50 10,647.50 10,618.50 10,166.00 9,539.50 8,996.50 8,483.50 8,110.00 7,636.50
Average Common Equity
6,319.50 5,871.50 5,575.00 5,347.00 5,131.00 4,810.50 4,659.50 4,703.00 4,540.50 4,208.00

Fold the line items

Columns are period end dates